A wastewater plant built by a pharmaceutical company with exempt facility bonds does not violate tax laws or rules because the waste’s acidity level has to be neutralized before it can be sent to a public treatment facility, the Internal Revenue Service ruled.

The ruling was made in a technical advice memorandum from the IRS office of chief counsel that was dated March 15 but not made public until late last week.

Subscribe Now

Independent and authoritative analysis and perspective for the bond buying industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.